Korchazhkina Olga, Yang Ying
Institute of Science and Technology in Medicine, School of Medicine, University of Keele, Thornburrow Drive, Hartshill, Stoke-on-Trent, ST4 7QB, UK.
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):295-8. doi: 10.1016/j.jchromb.2004.03.053.
A previously described method of measurement of malondialdehyde (MDA) in human urine after derivatisation with 2,4-dinitrophenylhydrazine (DNPH) was tested for a possibility of using methyl malondialdehyde (MeMDA) as an internal standard. Despite structural similarity, those compounds were found to produce different yields of derivatisation under the same conditions depending on urine matrix. We conclude, that MeMDA is not suitable as an internal standard for the measurement of MDA in urine under previously reported conditions when DNPH is used as a deriviatising agent.
用2,4-二硝基苯肼(DNPH)衍生化后测量人尿中丙二醛(MDA)的一种先前描述的方法,针对使用甲基丙二醛(MeMDA)作为内标的可能性进行了测试。尽管结构相似,但在相同条件下,根据尿液基质,发现这些化合物产生不同的衍生化产率。我们得出结论,当使用DNPH作为衍生剂时,在先前报道的条件下,MeMDA不适合作为尿液中MDA测量的内标。